$0.0600
-0.0030 (-4.76%)
At Close: Jun 03, 2026
NGM Biopharmaceuticals (NYSE:NGM) Shares Sold by UBS Group AG
04:22am, Monday, 22'nd Jun 2020
UBS Group AG cut its stake in shares of NGM Biopharmaceuticals (NYSE:NGM) by 60.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The
Bourse de Paris : Les valeurs à suivre à Paris et en Europe
04:00am, Monday, 22'nd Jun 2020First National Study Predicts an Escalating Epidemic of Nonalcoholic Fatty Liver Disease (NAFLD)
12:00am, Monday, 22'nd Jun 2020
First National Study Predicts an Escalating Epidemic of Nonalcoholic Fatty Liver Disease (NAFLD)
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
12:00am, Sunday, 21'st Jun 2020
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...
Sign In
Buy HEPA